1. Introduction {#s0005}
===============

Filamentous fungi significantly impact food security, crop production, drug development, and animal/human health. Several important discoveries in molecular biology were derived from studies using filamentous fungi. For instance, Beadle and Tatum used the model filamentous fungus *Neurospora crassa* in their early research in cell biology and proposed the well-known "one gene, one enzyme" hypothesis \[[@bb0005]\]. To this day, *N. crassa* remains a model system and is used in various areas of research including investigation on circadian rhythms, gene silencing, fungal development, and cell polarity \[[@bb0010]\]. Importantly, discoveries of fungal secondary metabolites, including antibiotics and statins, have contributed to saving the lives of millions of people, and enabled the development of several medical procedures and treatments. Penicillin, produced by *Penicillium chrysogenum*, was discovered for its ability to inhibit gram-positive bacteria and has led to clinically used derivatives that serve as broad-spectrum antibiotics \[[@bb0015]\].

Although filamentous fungi have contributed greatly to science, many filamentous fungi are pathogens that cause a reduction in crop production and human/animal health problems. *Magnaporthe oryzae* is the causal agent of rice blast disease, the most important fungal rice disease worldwide, and results in lesions on all parts of the plants such as leaves, panicles, and seeds \[[@bb0020]\]. *Fusarium oxysporum* causes the well-known Fusarium wilt disease on a wide range of agriculturally important host plants \[[@bb0025]\]. Typical symptoms include vascular browning of the xylem tissue, leaf yellowing, and wilting. Along with *Fusarium solani*, *F. oxysporum* is responsible for the majority of the cases of fusariosis in immunocompromisied patients resulting in a high mortality \[[@bb0030],[@bb0035]\]. Clinical infections caused by fungi within the genus *Aspergillus* are associated with 30%\~90% mortality \[[@bb0040],[@bb0045]\]. Some filamentous fungi produce mycotoxins that contaminate the food supply or affect plant or animal health. Some of the best known examples of mycotoxins include the carcinogenic aflatoxins synthesized by several *Aspergillus* species \[[@bb0050]\], and deoxynivalenol, a type B trichothecene produced predominantly by *Fusarium graminearum*, which may function by inhibiting protein synthesis \[[@bb0055]\].

The economic importance of filamentous fungi, has led to more focus on molecular studies on these microbes, but limitations in reverse genetic tools including gene deletion/editing, RNAi, protein expression, and gene tagging procedures have in some instances remained a challenge. While most filamentous fungi are haploid, those that are diploid or multinuclieated pose an additional complication for investigating the function of a gene, since all alleles need to be mutated to determine the contribution of the gene of interest to a particular phenotype. A popular method for gene deletion/disruption in fungi is based on homologous recombination (HR), where selective markers conferring resistance to antifungal compounds, usually to hygromycin or neomycin, are used to replace or integrate within the target locus. While some fungi such as *Saccharomyces cerevisiae*, *N. crassa*, and *Aspergillus* spp. may have a relatively high HR efficiency, gene disruption can be difficult for many non-model fungi due to a low HR efficiency. The development of the simple, rapid, powerful, and economical gene manipulation tool known as CRISPR/Cas9 technology opened a new era for genome editing. This technology has been widely used for genome editing of model and non-model higher organisms \[[@bb0060]\]. This technique and its rapid application to fungi has shown obvious advantages in gene manipulation when compared to previous methods since the CRISPR/Cas9 system induces double strand breaks in host cell DNA, enhancing the efficiency of gene manipulation and integration.

2. The Working Mechanism of the CRISPR/Cas9 System {#s0010}
==================================================

CRISPR (clustered regularly interspaced short palindromic repeats) is a family of DNA repeats found in \~40% of the sequenced bacterial genomes and \~90% of the archaeal genomes \[[@bb0065]\]. Cas9, a DNA endonuclease, forms a simple bacterial immune system with a crRNA/tracrRNA hybrid to recognize, bind, and ultimately cleave foreign DNA \[[@bb0070]\]. The crRNA/tracrRNA hybrid was later engineered into a single guide RNA (sgRNA) which facilitated experimental design \[[@bb0070]\].

The recognition of a DNA target region depends on a protospacer adjacent motif (PAM) which is located at the 3′-terminus of a 20 bp target sequence. Once the CRISPR/Cas9 complex recognizes the target DNA sequence, it will generate a double strand break (DSB) at the DNA target locus between the final third and fourth nucleotides which will activate the host DNA repair process. Two cellular DNA repair mechanisms, non-homologous end joining (NHEJ) and homologous recombination (HR), play essential roles in precise genome editing and gene manipulation ([Fig. 1](#f0005){ref-type="fig"}). NHEJ has been regarded as an error-prone repair mechanism that generates either short insertions or deletions of nucleotides in close proximity to the DSB site(s) \[[@bb0075]\]. If these short insertions or deletions exist in a gene coding region, or within a portion of the promoter involved in recruiting proteins involved in transcription, the function of the endogenous gene will be disrupted. Consequently, this procedure is widely used for generating gene mutations. However, an increasing amount of evidence has indicated that NHEJ is not always error-prone \[[@bb0080]\]. Recently, a homology independent targeted integration (HITI) strategy was devised that allows fragments to be integrated into the genome by NHEJ repair. Interestingly, the integration can occur in both dividing and non-dividing cells with a high probability of perfect DNA repair at the sgRNA cleavage site \[[@bb0085], [@bb0090], [@bb0095]\]. In HR, the second DSB repair pathway, the mechanism relies on a DNA template, allowing the foreign DNA fragment(s) to be precisely integrated into the host genome. However, HR-mediated DSB repair only occurs in dividing cells, limiting the application of this method to a broad range of uses.Fig. 1Overview of CRISPR/Cas9 gene editing system and DNA repair mechanisms. When complexed with a sgRNA, Cas9 will cleave double stranded DNA at a specific site directed by the target sequence and PAM of the sgRNA. Once the DNA is cleaved, two DNA repair pathways, NHEJ and HDR, occur and may alter the genome of the cell. In NHEJ, insertions or deletions of nucleotides may occur at the cleavage site; alternatively if multiple DSBs are generated, repair can occur between different fragments. During HDR homologous recombination occurs at the loci adjacent to the DBS using a DNA template.Fig. 1

3. Various Strategies for Developing CRISPR/Cas9 Tools in Filamentous Fungi {#s0015}
===========================================================================

Various versions of CRISPR/Cas9 tools have been developed for fungi and each of these approaches may be the preferred method for a particular fungus ([Table 1](#t0005){ref-type="table"}). The yeast *S. cerevisiae* was the first fungus for which CRISPR/Cas9 was applied to modify the genome \[[@bb0100]\], and the ability of this fungus to stably maintain plasmids facilitated the development of tools for CRISPR/Cas9. Usually these plasmids contain the *CAS9* gene under constitutive expression \[[@bb0100],[@bb0105]\], and when coupled with transient sgRNA cassette transformation, generate DSBs thereby increasing homologous recombination rates \[[@bb0100]\]. Previously, gene manipulation in the clinically relevant yeast *Candida albicans* was tedious as the fungus is a diploid; however development of CRISPR/Cas9 methods has provided an efficient way to generate homozygous mutations and facilitated genome engineering in this organism \[[@bb0105], [@bb0110], [@bb0115]\].Table 1Filamentous fungi in which CRISPR gene editing technology has been utilized.Table 1StrategiesFilamentous fungusGenome editingReferenceNHEJHDRI*CAS9* integration into fungal genome for expression*Beauveria bassiana*+\[[@bb0425]\]*Blastomyces dermatitidis*+\[[@bb0430]\]*Coprinopsis cinerea*+\[[@bb0435]\]*Cordyceps militaris*+\[[@bb0440]\]*Fusarium graminearum*++\[[@bb0300]\]*Ganoderma* spp.+\[[@bb0445]\]*Leptosphaeria maculans*+\[[@bb0295]\]*Myceliophthora* spp.++\[[@bb0450]\]*Nodulisporium* sp.+\[[@bb0455]\]*Rhizopus delemar*+\[[@bb0460]\]*Sporisorium scitamineum*+\[[@bb0465]\]*Trichoderma reesei*++\[[@bb0120]\]*Ustilaginoidea virens*+\[[@bb0470]\]*CAS9* transient expression*Fusarium fujikuroi*++\[[@bb0345]\]*Neurospora crassa*+\[[@bb0130]\]*Sclerotinia sclerotiorum*+\[[@bb0170]\]*Ustilago tricophora*++\[[@bb0475]\]Self-replicating plasmids (eg. AMA1-based)*Alternaria alternata*+\[[@bb0290]\]*Aspergillus aculeatus*+\[[@bb0185]\]*Aspergillus brasiliensis*+*Aspergillus carbonarius*+*Aspergillus luchuensis*+*Aspergillus nidulans*+*Aspergillus niger*+*Aspergillus oryzae*++\[[@bb0480]\]*Penicillium chrysogenum*+\[[@bb0190]\]*Talaromyces atroroseus*+\[[@bb0180]\]*Ustilago maydis*+\[[@bb0485]\]Cas9 RNPs*Aspergillus fumigatus*+\[[@bb0215]\]*Fusarium oxysporum*++\[[@bb0220]\]*Magnaporthe oryzae*++\[[@bb0230]\]*Mucor circinelloides*++\[[@bb0240]\]*Penicillium chrysogenum*+\[[@bb0190]\]*Penicillium decumbens*+\[[@bb0490]\]*Trichoderma reesei*+\[[@bb0495]\]Other*Shiraia bambusicola*+\[[@bb0500]\]

Following these initial CRISPR/Cas9 experiments with yeasts, the gene editing tool was adapted for both model and non-model filamentous fungi ([Table 1](#t0005){ref-type="table"}; [Fig. 2](#f0010){ref-type="fig"}). A CRISPR/Cas9 system was first established in the filamentous fungus *Trichoderma reesei* using a codon-optimized *CAS9* gene that was introduced into the genome using *Agrobacterium tumefaciens*-mediated transformation \[[@bb0120]\]. When the expression of *CAS9* was under the control of either a constitutive or inducible promoter, there was no obvious alteration in the function of other proteins as observed by fungal morphology and various other phenotypes. The successful integration of *Cas9* into the fungal genome generated a strain (a 'Cas9' strain) that requires only the sgRNA for genome editing through protoplast transformation, providing a method to rapidly target multiple genes simultaneously \[[@bb0120]\].Fig. 2Scheme of generating a 'Cas9' strain for gene editing. A fungus is transformed through protoplasts or *Agrobacterium tumefaciens*-mediated transformation with the *CAS9* gene under control of either an inducible or constitutive promoter generating a 'Cas9' strain. Once the *CAS9* gene has been stably integrated into the fungal genome, subsequent transformations allow various other loci of interest to be targeted by sgRNAs.Fig. 2

The random integration of the *CAS9* gene into the host genome may induce undesired mutations, and obtaining a 'Cas9' fungal strain may require screening several transformants or optimizing the codon usage of the *CAS9* gene to a different codon preference for each species. Another caveat is the constitutive expression of *CAS9* and/or its long-time retention in host cells which may generate off-target effects \[[@bb0125]\]. To overcome these limitations, transient expression systems of the *CAS9* gene and sgRNA in filamentous fungi have been utilized ([Fig. 3](#f0015){ref-type="fig"}). A transient expression CRISPR/Cas9 system was developed in the model filamentous fungus, *N. crassa* \[[@bb0130]\], where the *CAS9* gene was engineered with the *trpC* constitutive promoter from *A. nidulans*, and the Small Nucleolar RNA 52 (SNR52) promoter from *S. cerevisiae* was used to drive sgRNA expression. The editing efficiency gradually increased with an increasing number of copies of *CAS9* and the quantity of sgRNA plasmids. The replacement of the endogenous promoter of the *clr-2* gene with the *β-tubulin* promoter and the insertion of a codon optimized firefly luciferase cassette suggested that this strategy was efficient and could be applied to many aspects in filamentous fungi \[[@bb0130]\].Fig. 3CRISPR/Cas9 systems for filamentous fungi that do not integrate *CAS9*. Initially, the fungal cell wall is degraded generating protoplasts followed by introduction of transient self-replicating plasmids or Cas9 RNPs. I) Plasmid(s) encoding the sgRNA and *CAS9* are introduced into the protoplast and both of these components are expressed which combine to generate the DSB dictated by the sgRNA. The plasmids are rapidly degraded within the fungal cell. II) Self-replicating plasmids encoding the sgRNA and *CAS9*, and can be maintained for longer periods to time within the cell creating a higher probability of expression and Cas9 gene editing. III) Cas9 RNP transformation, where the purified Cas9 protein and the sgRNA are directly transformed into the fungal protoplasts. The Cas9 RNP is rapidly degraded during natural protein turnover.Fig. 3

It is not uncommon for fungi to have multiple nuclei within a single cell, have undergone whole or partial genome duplication \[[@bb0135], [@bb0140], [@bb0145], [@bb0150]\], or harbor supernumerary chromosomes \[[@bb0155], [@bb0160], [@bb0165]\], thus multiple genetic loci may need to be targeted within a single fungal cell. A CRISPR/Cas9 gene editing tool for the multinucleate filamentous phytopathogenic fungus *Sclerotinia sclerotiorum* has been reported \[[@bb0170]\]. *CAS9* and sgRNAs were able to be transiently expressed in the protoplasts and function properly; however, plasmid fragments of various lengths were integrated into the Cas9/sgRNA cleavage site by the NHEJ repair pathway, generating mutants with insertions of the plasmid \[[@bb0170]\]. Using this method, the *Ssoah1* gene, which is involved in the accumulation of oxalic acid, was disrupted and the *ΔSsoah1* strain was unable to acidify the growth medium \[[@bb0170]\].

Although filamentous fungi cannot stably maintain most plasmids, several chromosomal replicators, including AMA1 and MATE elements, have provided a possible mechanism for extrachromosomal maintenance of plasmids in filamentous fungi \[[@bb0175]\]. AMA1 plasmids can significantly enhance transformation efficiency, have a low probability of being inserted into the fungal genome during transformation, and are able to be easily lost after transformation without selection, allowing the dominant selectable marker(s) to be reused for additional transformation procedures. Based on these advantages, several CRISPR/Cas9 systems utilize AMA1 plasmids for filamentous fungi \[[@bb0180], [@bb0185], [@bb0190]\]. In one of the first studies using this method, Nødvig et al. successfully mutated the *yA* gene in *A. nidulans*, resulting in a change of color of conidia from yellow to green \[[@bb0185]\]. In this study, the expression of the sgRNA depended on two key components, an intrinsic hammerhead ribozyme and a hepatitis delta virus ribozyme. Both can be self-cleaved and allow the precise initiation of the sgRNA \[[@bb0185]\].

All of these CRISPR/Cas9 systems in filamentous fungi require functional host transcription and translation systems for the expression of the foreign *CAS9* gene and sgRNA transcription. Appropriate promoters must be chosen for both *CAS9* and sgRNA expression, requiring optimization of promoters in different filamentous fungi. In addition, the synthesis of sgRNA is controlled by the RNA polymerase III (Pol III) promoters like the U6 promoter and requires precise transcription initiation \[[@bb0100],[@bb0105]\]. A considerable amount of time and effort is necessary for optimizing a plasmid-based Cas9/sgRNA delivery method. Consequently, more recent attempts have used a Cas9 RNP-based delivery method for genome editing in different species, including Arabidopsis, fruit fly, zebrafish, and human cell lines \[[@bb0195], [@bb0200], [@bb0205], [@bb0210]\]. Cas9 RNPs consist of the purified Cas9 protein and an *in vitro* transcribed sgRNA, and both components are assembled *in vitro* into a complex and then directly transfected into the host cells. Compared to plasmid-based delivery, the Cas9 RNP-based delivery has several advantages including: 1) the expression of the *CAS9* gene and transcription of the sgRNA does not rely on host machinery, and therefore the precise transcription initiation of the sgRNA is not a concern; 2) the assembled Cas9 RNPs have immediate cleavage activity and can be directly delivered into the host cells to target the specified DNA locus without having to express *CAS9* or transcribe the sgRNA; 3) the cleavage efficiency of the different sgRNAs can be evaluated *in vitro*, allowing the optimal sgRNA(s) to be chosen for further experiments; 4) Cas9 RNPs will be depleted over a short timeframe from the host cells by protein degradation pathways, thereby reducing the possibility of Cas9 off-target activity.

Cas9 RNP-based delivery methods have been developed for filamentous fungi primarily using the polyethylene glycol (PEG)-mediated protoplast transformation technique to introduce the Cas9 RNPs to the recipient protoplasts. A simple and universal CRISPR/Cas9 system based on *in vitro*-assembled Cas9 RNPs has been reported in *A. fumigatus* \[[@bb0215]\], in which two strains, the WT and a *ΔakuB* strain (reduced in frequency of NHEJ), were used in a study of the CRISPR/Cas9-mediated HR repair mechanism to disrupt *pksP*, a gene responsible for the green color of the conidia. The hygromycin resistance cassette flanked by two microhomology sequences (35--50 bp) at both ends of the cassette were able to serve as both the selective marker and the donor template for insertion into the Cas9 RNP cleavage site(s). With the *ΔakuB* laboratory strain, up to 97% of the colonies showed the desired phenotype regardless of whether a 35 bp or 50 bp homologous sequence was used, while the efficiency was 40--74% in the WT, where the length of microhomology directly influenced the integration efficiency \[[@bb0215]\].

In another example, a stable Cas9 RNP transformation method was developed for the phytopathogenic filamentous fungus *F. oxysporum*. The nuclear localization sequence (NLS) from the histone *H2B* gene of *F. oxysporum* was fused with the Cas9 coding sequence and once purified, was transferred into fungal protoplasts for CRISPR-mediated gene editing. Mutations in two classical marker genes for fungal biology, *URA5* and *URA3*, were generated during development of the system as a proof of concept *via* PEG-mediated transformation. When a homology directed repair strategy was utilized to integrate a dominant selectable marker into the *FoBIK1* gene, encoding the key polyketide synthase responsible for the synthesis of the pigmented secondary metabolite bikaverin, the maximum efficiency was \~50% \[[@bb0220]\]. Based on this method, several endogenous genes were tagged at the native gene locus using the sGFP and mCherry fluorescent markers \[[@bb0225]\]. Importantly, as the NLS of this Cas9 protein was derived from the well conserved sequence of the histone H2B, this system may be widely applicable to the other members within the genus *Fusarium* and perhaps other fungi.

A Cas9 RNP-mediated co-editing and counter selection system has also been developed for the rice blast fungus, *M. oryzae* \[[@bb0230]\]. In this system, only a 30 bp homologous sequence was necessary to promote HR-directed repair flanking the Cas9 RNP cleavage site when generating an *ALB1* mutant unable to produce melanin \[[@bb0230]\]. However, when the NHEJ strategy was attempted to mutate the *ALB1* gene without addition of a donor template during the transformation, the frequency of generating the desired transformant was reduced, although mutants were able to be identified due to the easily distinguished phenotype. While these results suggest this strategy is less suitable for gene disruption, it was used to generate a single nucleotide substitution in the *M. oryzae SDI1* gene, conferring resistance to the fungicide carboxin \[[@bb0230]\]. A strategy to edit two loci simultaneously was attempted, but the efficiency for this strategy was only \~1% and one genetic locus must have an obvious mutant phenotype enabling selection. Cas9 RNP-mediated transformation methods have been reported in other filamentous fungi including *P. chrysogenum* and *Mucor circinelloides* \[[@bb0235],[@bb0240]\]. Collectively these studies indicate that Cas9 RNP-mediated transformation offers a simple and reliable method that could be adapted for use in other filamentous fungi and could be implemented for other CRISPR/Cas9-based molecular techniques.

4. Applications of CRISPR/Cas9 Tools for Filamentous Fungal Genome Engineering {#s0020}
==============================================================================

The emergence of CRISPR/Cas9 tools has sparked a revolution in genome engineering for various organisms. The most exciting application of CRISPR/Cas9 technology focuses on precise gene editing, offering vast possibilities to modify organisms as desired ([Fig. 4](#f0020){ref-type="fig"}). In addition, derivatives of CRISPR/Cas9 enzymes can be utilized for several activities including base editing, DNA nicking, and epigenetic modification \[[@bb0245],[@bb0250]\]. One of these variants that has found a wide range of uses is dCas9, which has a mutation in the endonuclease domain of Cas9 resulting in a loss of DNA cleavage activity. Transcriptional repression by dCas9 is achieved by targeting the transcriptional initiation or elongation regions thereby reducing the amount of mRNA generated through competitive inhibition. In human cells, this interference efficiency can be up to 90% \[[@bb0255]\]. Conversely, CRISPR/Cas9-based transcriptional activation (CRISPRa) is considered a powerful tool for overexpression of a target gene \[[@bb0260]\]. In this technique, either the transcriptional activation domain or the entire protein is fused with dCas9, facilitating the recruitment and assembly of the RNA transcriptional machinery to the target site specified by the sgRNA, ultimately driving an increase in gene expression. CRISPRa has the potential for widespread use in investigating fungal gene expression, especially concerning the expression of genes involved in secondary metabolite biosynthesis. Filamentous fungi are well-known to produce an arsenal of natural products with biological activity, and many of the genes responsible for the biosynthesis of these secondary metabolites are clustered together and are not transcribed under standard culturing conditions \[[@bb0265],[@bb0270]\]. Identification of a suitable environment for activating the expression of these secondary metabolite biosynthetic clusters can be time-consuming and tedious, although some success has been achieved with a few activation strategies including the manipulation of global or specific regulators \[[@bb0275]\]. However, the specific secondary metabolite(s) produced by a large number of cryptic/silent secondary metabolite gene clusters remains unknown, and development of CRISPR/Cas9 technologies can serve as a valuable tool to elucidate the compounds produced by these clusters ([Fig. 4](#f0020){ref-type="fig"}). Although most of the currently developed CRISPR/Cas9 systems have been utilized primarily for functional characterization of genes in filamentous fungi, some other applications, including investigation of the subcellular localization of proteins and gene regulation, have been recently reported in filamentous fungi \[[@bb0225],[@bb0280]\].Fig. 4Application of CRISPR/Cas9 technology in filamentous fungi. While there are many potential applications of CRISPR/Cas9 technology for fungi, some of the most common that are currently employed are gene deletion/disruption and generation of gene fusions.Fig. 4

4.1. CRISPR/Cas9-Mediated Gene Disruption/Deletions {#s0025}
---------------------------------------------------

The initial establishment of CRISPR/Cas9 tools in filamentous fungi was mostly focused on generating gene disruptions using NHEJ and HR strategies ([Fig. 1](#f0005){ref-type="fig"}, [Fig. 4](#f0020){ref-type="fig"}). The plethora of suitable target genes that provide an easily observable phenotype played an important role in the rapid development of CRISPR/Cas9 tools. Usually the system involved targeting either biosynthetic genes responsible for pigment production and/or resistance-related genes since they have obvious phenotypes once disrupted. Some of the pigment biosynthetic genes that have been targeted include the *yA* gene (green/yellow) of *A. nidulans*, the *albA* gene (black/white) of *A.niger* \[[@bb0185]\], the *pksP* gene (green/white) of *A. fumigatus* \[[@bb0215],[@bb0285]\], the *pks17* gene (green/white) of *P. chrysogenum* \[[@bb0190]\], the *pksA* gene (black/white) of *A. alternata* \[[@bb0290]\], the *FoBIK1* gene (purple/white) of *F. oxysporum* \[[@bb0220]\], and the *ALB1* (black/white) and *RSY1* genes (black/orange) of *M. oryzae* \[[@bb0230]\]. While the resistance-related genes that have been used in the development of CRISPR systems include orthologs of the uracil biosynthetic genes *URA3* and/or *URA5* which confer resistance to 5-fluoroorotic acid (5-FOA) when disrupted \[[@bb0185],[@bb0220],[@bb0240]\], the osmosensor histidine kinase *Os1* in *Leptosphaeria maculans* and *F. graminearum* conferring resistance to the phenylpyrrole and dicarboximide classes of fungicides \[[@bb0295],[@bb0300]\], and the *SDI1* gene of *M. oryzae* conferring fungicide resistance to carboxin \[[@bb0230]\]. These studies indicated that most of the gene disruptions by NHEJ contained either short insertions or deletions of nucleotides at the Cas9 cleavage site, resulting in frameshift mutations. Gene disruptions by HR have been based on the integration of a dominant selectable marker, usually conferring resistance to an antifungal compound, at the Cas9/sgRNA cleavage site(s) disrupting the coding sequence of the gene of interest.

4.2. Generation of Gene Fusions Based on CRISPR/Cas9 Technology {#s0030}
---------------------------------------------------------------

Investigation of the protein subcellular localization using fluorescent markers plays an important role in characterizing the compartmentalization and intracellular movement of a protein. A gene can be tagged at the N- or C-terminus, but N-terminus tagging is usually a more complex process in order to avoid disruption of upstream regulatory elements. The precision provided by CRISPR/Cas9 genome editing has accelerated development in this area, and enabled fluorescent markers to be precisely fused to endogenous genes at their native locus ([Fig. 4](#f0020){ref-type="fig"}) \[[@bb0225],[@bb0230],[@bb0280],[@bb0285]\]. Fluorescent marker tagging mainly depends on two strategies, homology-dependent and homology-independent, and currently most gene tagging using CRISPR/Cas9 technology in filamentous fungi is homology-dependent relying on HR-mediated DNA repair for integration of the fluorescent marker into the fungal genome. For example, in *A. fumigatus*, a GFP tag flanked with only 39 bp of homologous sequence was correctly integrated at the N-terminus of the *cnaA* gene, encoding the catalytic subunit of calcineurin, without the introduction of a selective marker \[[@bb0285]\]. A CRISPR-mediated co-editing strategy allowed editing at the *SEP6* gene locus while simultaneously tagging the *SEP5* gene with *GFP* at the N-terminus in *M. oryzae*, allowing visualization of GFP-Sep5 at the septin ring of the appressorium \[[@bb0230]\]. CRISPR/Cas9-mediated gene tagging can be also accomplished by a HITI strategy requiring the ligation of two separate DNA fragments/chromosomes at the Cas9 cleavage site \[[@bb0090]\]. Based on conservation in the DNA repair mechanism, this strategy has been used in *F. oxysporum* to fuse two endogenous genes with fluorescent markers \[[@bb0225]\]. This strategy enabled a Cas9 cleaved plasmid containing the fluorescent marker sequence to be ligated into the *F. oxysporum* genome at the Cas9 DNA cleavage site, tagging FoChs5 with 3 × sGFP at the C-terminus and FoSso2 with mCherry at the N-terminus \[[@bb0225]\]. This method has also been used to tag the scytalone dehydratase encoding *SDH* gene in *M. oryzae* at the C-terminus with GFP where a single CRISPR target site within the gene coding region facilitated the crossover event \[[@bb0280]\].

4.3. Investigation of Gene Regulation in Fungi *via* CRISPR/Cas9 Technology {#s0035}
---------------------------------------------------------------------------

Another important application of CRISPR/Cas9 technology has concerned the investigation of gene regulation in filamentous fungi. A large number of fungal genes are only expressed under specific conditions and include secondary metabolite biosynthetic genes, host-specific virulence factors, and some key regulatory genes. Expression profiles of many genes are dependent on environmental factors including light, salt, temperature, humidity, pH, and other stressors \[[@bb0305],[@bb0310]\]. Use of CRISPR/Cas9-based genome editing has facilitated the exploration of gene expression profiles ([Fig. 4](#f0020){ref-type="fig"}). In *N. crassa*, the protein levels of histone H2B were used as an *in vivo* indicator for the amount of DNA in cells, and CRISPR/Cas9 was used to tag the endogenous histone H2B gene at the C-terminus with a codon-optimized firefly luciferase (*H2B::LUC*) \[[@bb0315]\]. The bioluminescence of the transformant strain displayed a circadian rhythm, indicating DNA synthesis in *N. crassa* was under control of the proteins that govern the circadian rhythm \[[@bb0315]\]. A similar strategy could be applied to study the expression of silent secondary metabolite gene clusters, where a molecular reporter, such as *lacZ* or fluorescent genes, can be fused to the key biosynthetic gene in the cluster enabling the expression of the gene/cluster of interest to be easily detected under different environmental conditions.

5. Challenges for Developing CRISPR/Cas9 Tools in Filamentous Fungi {#s0040}
===================================================================

Although a large number of filamentous fungal genomes have been sequenced and have contributed immensely to the understanding of fungal diversity and evolution, the reverse genetic techniques necessary to functionally characterize the genes of interest can be improved upon for most filamentous fungi. The emergence of CRISPR/Cas9-mediated genome editing has spurred a new era for functional genomics, and the rapid adoption of this technology for editing filamentous fungal genomes foreshadows the enormous potential for genome manipulation. Due to the diverse nature of the fungal kingdom, it can be difficult to develop a universal method for gene editing in filamentous fungi. Consequently, several CRISPR/Cas9 systems have been developed and optimized specifically for individual filamentous fungi or a specific genus, and each system may have different advantages and disadvantages. During the process of developing a CRISPR/Cas9 system for a particular fungus, several challenges may be encountered and can range from determining the optimal expression method for the *CAS9* gene including the choice of promoter and the identification of a suitable NLS that allows it to be translocated to the nucleus, to the assessment and mitigation of undesired off-target cleavage by Cas9. Further exploration of these common challenges encountered during development of CRISPR/Cas9 systems is warranted as it could facilitate the development and use of Cas9 tools in other filamentous fungi.

5.1. Expression of the *CAS9* Gene in Filamentous Fungi {#s0045}
-------------------------------------------------------

The expression of *CAS9* can be under the control of either a constitutive or an inducible promoter. Increasing evidence has shown that high levels of Cas9 protein may have a toxic effect to host cells. The influence of Cas protein levels on toxicity was investigated in the yeast *S. cerevisiae*, where the expression of *CAS9* was placed under the control of a galactose inducible promoter \[[@bb0100]\]. When both the sgRNA and *CAS9* were highly expressed there was a reduction in cell viability when compared to control yeast cells, indicating possible toxicity due to the high levels of Cas9 DNA cleavage activity \[[@bb0100]\]. These observations are further supported by similar findings in other organisms. Evidence of Cas9 toxicity was observed in the green alga *Chlamydomonas reinhardtii* when *CAS9* was constitutively expressed \[[@bb0320]\], and *in vivo* expressed Cas9 toxicity has also been shown in the cyanobacterium *Synechococcus elongatus* \[[@bb0325]\], the parasite *Trichomonas vaginalis* \[[@bb0330]\], and in human cells \[[@bb0335]\].

Studies have indicated that the codon usage of the *CAS9* gene may have an influence on Cas9 toxicity, while constitutive *in vivo CAS9* expression might be suitable for some filamentous fungi. A codon-optimized *CAS9* gene under the control of the *amyB* promoter was constitutively expressed in *A. oryzae* without causing detrimental effects in growth \[[@bb0340]\]. Similarly, a codon-optimized *CAS9* fused with the *GFP* coding sequence under either a constitutive or an inducible promoter was integrated into the *T. reesei* genome *via Agrobacterium*-mediated transformation and the resulting transformants displayed strong nuclear fluorescence and appeared to have normal morphology and growth \[[@bb0120]\]. Conversely, Foster et al. was unable to obtain transformants that stably expressed the *CAS9* gene in *M. oryzae* despite using different variants of *CAS9* and several promoters \[[@bb0230]\]. Transformation with these plasmids and sgRNA generated a fewer number of transformants, suggesting constitutive *CAS9* expression could be toxic in *M. oryzae*, and gene editing was ultimately accomplished by transient introduction of purified Cas9 protein with *in vitro* synthesized sgRNAs \[[@bb0230]\]. All of these results indicate that optimizing *CAS9* expression in filamentous fungi can be a complex process.

5.2. Selection of the NLS for Cas9 {#s0050}
----------------------------------

Cas9 must enter the host nucleus to carry out cleavage of the DNA. The diversity within fungi complicate the identification of a universal NLS that is suitable for all fungi, and therefore the NLS sequence of Cas9 may need to be optimized for efficient nuclear entry in filamentous fungi. The selection of an appropriate NLS may be based on previous assessment of an NLS sequence or alternatively choosing a NLS of a native nuclear protein. The NLS from the endogenous gene *H2B* of *F. oxysporum* was identified by multiple sequence alignment and was fused to the N-terminus of the *CAS9* gene. This NLS had protein solubility suitable for protein purification and did not significantly influence Cas9 cleavage activity \[[@bb0220]\]. A comparison of NLS sequences fused to Cas9 indicated the NLS can influence gene editing efficiency. Three different NLSs, SV40, H2B~NLS~, and VEV~NLS~, were fused to Cas9 and the gene editing efficiency assessed in *F. fujikuroi*, a close relative of *F. oxysporum*, and of the three variants, the Cas9 containing the endogenous NLS from histone H2B had a significantly higher gene editing efficiency \[[@bb0345]\].

5.3. Off-Target Activity {#s0055}
------------------------

An important concern using CRISPR/Cas9 technology is the potential for off-target effects, where Cas9 causes an undesired DSB at an unintended chromosomal locus. Although the cleavage specificity of Cas9 is controlled by the 20 nt target sequence of the sgRNA and the presence of the PAM element, potential off-target cleavage is able to occur at loci with a high percentage of nucleotide identity to the sgRNA sequence \[[@bb0350],[@bb0355]\]. In addition, different sgRNA structures can also influence the frequency of an off-target event occurring \[[@bb0355]\]. The off-target effect can limit the wide application of CRISPR/Cas9 technology in various organisms, and several approaches may increase CRISPR specificity and thereby reduce the likelihood of an off-target effect. The most critical parameter to limit off-target effects is the design of the sgRNA. The "seed" sequence of the sgRNA-guiding sequence, 10--12 bp adjacent to the PAM element, dictates Cas9 cleavage specificity \[[@bb0070]\], while the PAM element is necessary to permit unwinding and formation of secondary structures for DNA cleavage \[[@bb0070]\]. sgRNAs that contain over 17 identical nucleotides to another locus of the genome, are likely to have an unintended off-target cleavage at this secondary locus \[[@bb0355]\]. Additionally, truncated sgRNAs, containing 17--18 nt of target sequence, had higher specificity than the full length \[[@bb0360]\]. Taken together, designing a unique sgRNA, especially at the "seed" region, that does not share high DNA identity with other genetic loci greatly limits the probability of off-target cleavage with Cas9. Another factor that can influence the likelihood of an off-target event is the method of transformation, where plasmid-mediated transfection is responsible for more off-target events than Cas9 RNP-mediated transfection \[[@bb0365],[@bb0370]\]. Newer modified versions of Cas9, such as "enhanced specificity" Cas9 \[[@bb0375]\] and high fidelity Cas9-HF1 \[[@bb0380]\], are available and may reduce the chances of off-target mutations occurring during transformation.

The probability of off-target mutations have been assessed in *A. fumigatus*. After transformation of the fungus with either a high concentration of Cas9 RNPs (1 μg/μL) or a low concentration (0.5 μg/μL), whole genome sequencing revealed there was no significant difference in the number of mutations in either one of the Cas9 RNP mediated transformations when compared to traditional transformation \[[@bb0385]\]. Additionally, there was no difference in the types of mutations that occurred between these groups, as the number of insertions and deletions were similar, and the locations of the mutations were predominantly located in intergenic regions \[[@bb0385]\]. In another study, off-target mutations were evaluated after CRISPR/Cas9-mediated transformation directed to *TRI5* in *F. graminearum* \[[@bb0300]\]. A sgRNA targeting *TRI5* shared 14 bp with two other loci within the genome, and sequencing of these loci after transformation revealed no mutations occurred at either location.

5.4. Transformation Methods With High Efficiency {#s0060}
------------------------------------------------

Several genetic transformation methods are readily used for filamentous fungi including protoplast-mediated transformation, *Agrobacterium*-mediated transformation, and electroporation, but the transformation efficiency for these methods is usually low. The efficiency of protoplast-mediated transformation is in the order of one transformant generated per 1--10 million fungal protoplasts, although there is a very high degree of variability \[[@bb0390]\]. Because of this limitation, all established CRISPR/Cas9 tools in filamentous fungi have so far relied on the use of a selective marker or obvious phenotypic change to identify the desired transformant. Although techniques are available for removing these selective markers, these methods can be time-consuming and be experimentally challenging to conduct. Consequently, development of a highly efficient transformation method could greatly aid in the application CRISPR/Cas9 technology in filamentous fungi, and once transformation methods achieve a higher efficiency, gene editing could potentially be conducted without introducing a selective marker.

Several methods can potentially be used in filamentous fungi to increase transformation efficiencies. First, microinjection methods have been widely used in animal oomycetes and insect eggs with the advantage of directly delivering Cas9/sgRNA components into the host cells \[[@bb0395]\]. Although some filamentous fungi produce conidia with a single nucleus, the size of the conidia is usually small, making it difficult to adapt applications involving microinjection to filamentous fungi. In spite of difficulties, Toyoda et al. were able to successfully inject fluorescein-isothiocyanate-conjugated albumin into the cytoplasm of conidia from *Erysiphe graminis* f. sp. *hordei* \[[@bb0400]\], suggesting this technique may have potential for use in introduction of CRISPR/Cas9 molecules. Nano-delivery is another mechanism that has potential for transferring Cas9 RNPs and has been used to translocate genes, siRNA molecules, and proteins into host cells \[[@bb0405]\]. A nonviral delivery vehicle for the Cas9 RNP, termed CRISPR-Gold, has been used for gene editing in the brains of adult mice \[[@bb0410]\]. Once identified, suitable nanoparticles for use in filamentous fungi could be adapted for the delivery of exogenous genes or proteins into fungal cells. Alternatively, cell-penetrating peptides may have promise and have been shown to be able to enter into *Candida* spp. \[[@bb0415],[@bb0420]\].

6. Conclusions {#s0065}
==============

Filamentous fungi have played an integral role in agriculture, industry, drug development, and biodegradation. As genome sequencing techniques improve and the associated costs decrease, the gap between sequence information and functional assessment will widen. Although having been available for less than a decade, the precise genome editing provided by CRISPR/Cas9 systems facilitates genetic manipulation and has been already adapted for several filamentous fungi. CRISPR/Cas9 technology could greatly aid in the use of fungi as biological factories, in particular manipulation of secondary metabolite biosynthetic genes which may be useful in developing bioactive products or derivatives for medicine. In addition, this tool will be valuable in fungal biology and investigation of the molecular interactions between fungal pathogens and their hosts. Although this tool is primarily used for gene disruptions, further improvements to CRISPR/Cas9 systems will increase its utility for various applications in filamentous fungi in the future.
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